These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11363326)

  • 1. HIV and the cells it infects: sorting the latent from the labile. An interview with Mike McCune, MD, PhD. Interview by Mark Mascolini.
    McCune JM
    J Int Assoc Physicians AIDS Care; 1996 Jan; 2(1):20-2, 25-7, 41. PubMed ID: 11363326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How far can you knock down HIV? An interview with David D. Ho, MD. Interview by Mark Mascolini.
    Ho DD
    J Int Assoc Physicians AIDS Care; 1997 Jun; 3(6):40-4. PubMed ID: 11364429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A need for clear animal data--"and the animal might have to be man". An interview with Robert L. Coffman, PhD. Interview by Mark Mascolini.
    Coffman RL
    J Int Assoc Physicians AIDS Care; 1995 May; 1(4):23-4. PubMed ID: 11362506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scanning the headlines with Jay A. Levy, MD. Interview by Mark Mascolini.
    Levy JA
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):40-4. PubMed ID: 11363530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New antiretroviral tactics: transitions or mere trends? An interview with Joep Lange,MD,PhD. Interview by Mark Mascolini.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1999 Jul; 5(7):25-9. PubMed ID: 11367133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An interview with Simon Wain-Hobson, PhD. Interview by Mark Mascolini.
    Wain-Hobson S
    J Int Assoc Physicians AIDS Care; 1995 May; 1(4):8-13. PubMed ID: 11362509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance, recombination, evolution--and chance: an interview with Andrew J. Leigh Brown, PhD. Interview by Mark Mascolini.
    Brown AJ
    J Int Assoc Physicians AIDS Care; 1997 Jul; 3(7):34-7. PubMed ID: 11364471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of replication of primary HIV-1 isolates in huPBL-NOD/Scid mice by antibodies from HIV-1 infected patients.
    Steyaert S; Heyndrickx L; Verhoye L; Vermoesen T; Donners H; Fransen K; Van Wanzeele F; Vandergucht B; Vanham G; Leroux-Roels G; Vanlandschoot P
    Antiviral Res; 2007 Aug; 75(2):129-38. PubMed ID: 17379323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune strategy.
    Proj Inf Perspect; 2004 Jan; (37):21-3. PubMed ID: 15119287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cofactors, coreceptors, and new retroviruses. An interview with Robin A Weiss, PhD. Interview by Mark Mascolini.
    Weiss RA
    J Int Assoc Physicians AIDS Care; 1995 Feb; 1(1):6-10. PubMed ID: 11362234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection.
    Barbour JD; Hecht FM; Wrin T; Segal MR; Ramstead CA; Liegler TJ; Busch MP; Petropoulos CJ; Hellmann NS; Kahn JO; Grant RM
    J Infect Dis; 2004 Jul; 190(2):251-6. PubMed ID: 15216458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference and HIV-1 infection.
    Kanzaki LI; Ornelas SS; Argañaraz ER
    Rev Med Virol; 2008; 18(1):5-18. PubMed ID: 17764099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In search of the Holy Grail: Martin Markowitz, M.D., on the dream of eradication.
    Markowitz M
    Res Initiat Treat Action; 1998 Apr; 4(2):9-13. PubMed ID: 11365230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summaries from the Eleventh Annual Houston Conference on AIDS in America.
    Res Initiat Treat Action; 1999 Jul; 5(3):13-25. PubMed ID: 11366719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired replication of protease inhibitor-resistant HIV-1 in human thymus.
    Stoddart CA; Liegler TJ; Mammano F; Linquist-Stepps VD; Hayden MS; Deeks SG; Grant RM; Clavel F; McCune JM
    Nat Med; 2001 Jun; 7(6):712-8. PubMed ID: 11385509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An interview with David A. Cooper, MD, DSc. Interview by Mark Mascolini.
    Cooper DA
    J Int Assoc Physicians AIDS Care; 1996 Mar; 2(3):17-22. PubMed ID: 11363343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel approach to HIV therapy: highly active antiretroviral therapy and autologous hematopoietic cell transplantation.
    Pippi F
    Med Hypotheses; 2008; 70(2):291-3. PubMed ID: 17681707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A viral load-based cellular automata approach to modeling HIV dynamics and drug treatment.
    Shi V; Tridane A; Kuang Y
    J Theor Biol; 2008 Jul; 253(1):24-35. PubMed ID: 18083195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the intra-host dynamics of HIV-1 infections.
    Stilianakis NI; Schenzle D
    Math Biosci; 2006 Jan; 199(1):1-25. PubMed ID: 16343556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine.
    Bhardwaj N; Walker BD
    Nat Med; 2003 Jan; 9(1):13-4. PubMed ID: 12514710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.